Use your antibodies-online credentials, if available.
LPAR5 encodes a member of the rhodopsin class of G protein-coupled transmembrane receptors. 再加上，我们可以发Lysophosphatidic Acid Receptor 5 抗体 (32) 和 Lysophosphatidic Acid Receptor 5 蛋白 (5)和数多这个蛋白质的别的产品。
These results suggest that the diverse roles of LPA4 (显示 LPAR4 ELISA试剂盒), LPA5 and LPA6 (显示 LPAR6 ELISA试剂盒) are involved in the activation of tumor progression in pancreatic cancer cells.
Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma.
MMP-2 (显示 MMP2 ELISA试剂盒) and MMP-9 (显示 MMP9 ELISA试剂盒) were found in HT1080L5 cells, in comparison with control cells. These results suggest that LPA (显示 APOA ELISA试剂盒) signaling via LPA5 negatively regulates the cell motile and invasive activities of human sarcoma cells.
These results suggest that LPA5 may act as a negative regulator of cellular responses in mouse fibroblast 3T3 cells, similar to the case for LPA1 (显示 LPAR1 ELISA试剂盒).
It was shown that lysophosphatidic acid 5 receptor transactivated the epidermal growth factor receptor (显示 EGFR ELISA试剂盒) and that inhibition of epidermal growth factor receptor (显示 EGFR ELISA试剂盒) blocked lysophosphatidic acid 5 receptor-dependent activation of NHE3 (显示 SLC9A3 ELISA试剂盒).
LPA5 is a bona fide LPA (显示 APOA ELISA试剂盒) receptor on human mast cells responsible for the majority of LPA (显示 APOA ELISA试剂盒) induced MIP-1beta (显示 CCL4 ELISA试剂盒) release.
LPA4 (显示 LPAR4 ELISA试剂盒) and LPA5 receptors induce osteoblastic differentiation of human mesenchymal stem cells
Data show that CLL cells express LPA receptors LPA(1-5) and VEGF receptors, and the plasma levels of VEGF are elevated in CLL patients.
GPR92 is proposed as a fifth LPA (显示 APOA ELISA试剂盒) receptor, LPA5, which likely has distinct physiological functions in view of its expression pattern.
FPP (显示 FDFT1 ELISA试剂盒) and NAG (显示 NAGLU ELISA试剂盒) play a role in the sensory nervous system through activation of GPR92
These findings suggest that tumor and stromal LPA receptors, in particular LPA1 (显示 LPAR1 ELISA试剂盒) and LPA5, play different roles in invasion and the seeding of metastasis
Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response
These data expand the influences of LPA signaling in neuropathic pain through a second LPA receptor subtype, LPA(5), involving a mechanistically distinct downstream signaling pathway compared with LPA(1 (显示 LPAR1 ELISA试剂盒)).
Lysophosphatidic acid (LPA) is a potent stimulant of NHE3 (显示 SLC9A3 ELISA试剂盒) and fluid absorption in the intestine, signaling through LPA(5). Regulation by LPA(5) depends on its interaction with NHERF2 (显示 SLC9A3R2 ELISA试剂盒).
GPR92 is highly expressed in the lymphocyte compartment of the gastrointestinal tract
Our data indicate that GPR93 can contribute to the observed induction of CCK expression and secretion by peptone and provide evidence that G protein-coupled receptors can transduce dietary luminal signals.
This gene encodes a member of the rhodopsin class of G protein-coupled transmembrane receptors. This protein transmits extracellular signals from lysophosphatidic acid to cells through heterotrimeric G proteins and mediates numerous cellular processes. Many G protein receptors serve as targets for pharmaceutical drugs. Transcript variants of this gene have been described.
G protein-coupled receptor 92
, G-protein coupled receptor 92
, G-protein coupled receptor 93
, LPA receptor 5
, lysophosphatidic acid receptor 5
, putative G protein-coupled receptor 92